SCHEMBL25577695

SCHEMBL25577695

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc(-c3ccc4c(c3)oc3ccccc34)cc2)c2ccc(-c3ccc4c(c3)oc3ccccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ AHR P35869 2/20 0.35
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ PLA2G10 O15496 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ PRKDC P78527 2/20 0.33
▸ NTRK1 P04629 1/20 0.32
▸ PLK3 Q9H4B4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579364 1.00 MMP12 (0.38) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25579380 1.00 MMP12 (0.38) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25579324 0.99 MMP12 (0.37) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25579458 0.99 MMP12 (0.37) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25577422 0.98 MMP12 (0.36) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25579339 0.97 MMP12 (0.36) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25577701 0.97 PLA2G2A (0.38) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25577670 0.96 MMP12 (0.35) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25579258 0.95 MMP12 (0.36) MMP12MMP13AHRPLA2G2APLA2G4A
SCHEMBL25578772 0.95 PLA2G2A (0.36) MMP12MMP13AHRPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 MMP12 3690/4885MMP13 4069/4885AHR 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback